• Corpus ID: 13241128

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome.

  title={The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome.},
  author={Yu O Timovska and V. M. Pivnyuk and Igor N. Todor and Nikolay Anikusko and Vasyl Chekhun},
  journal={Experimental oncology},
  volume={33 3},
The incidence of breast cancer has been increasing recently worldwide. Therefore, the search for the novel techniques for diagnosis and treatment as well as the studies elucidating pathogenetic mechanisms associated with tumorogenesis and delineating the molecular markers useful for diagnostics and monitoring of the disease are the topical issues of the day. The tumor develops in the setting of the metabolic disorders. In particular, tumor growth is accompanied by the impaired lipid metabolism… 

Figures and Tables from this paper

Evaluation of Serum Lipids and C-peptide among Breast Cancer Patients with Chemotherapy

Altered serum lipid parameters and C-peptide indicated the risk of cardiovascular diseases and diabetes in cancer patients and Routine assessments of these parameters are necessary for follow up care during breast cancer management.

A case-control study of the lipid profile of women with breast cancer

Community and oncology nurses, having considerable knowledge about health and lifestyle of their patients, should be more involved in basic education to decrease cancer risk, especially by women with alarming LDL-C level.

Significance of the plasma lipid profile in cases of carcinoma of cervix: a tertiary hospital based study.

The study showed TG is elevated in cervical cancer, and that TC and LDL-C are proportional to the spread of cancer as it increases from stage I to stage IV.

Chapter 4 Cancer Associated Dyslipidemia

This book chapter will emphasize on dyslipidemia in relationship to the cancer risk, diagnosis, prognosis and mortality incidents.

Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis.

Higher rosiglitazone dose alleviated some metabolic alterations resulting from cancer progression more effectively but induced a prominent cardiac hypertrophy.

One-Cell Analysis as a Technique for True Single-Cell Analysis of Organelles in Breast Tumor and Adjacent Normal Tissue to Profile Fatty Acid Composition of Triglyceride Species

A demonstration of the analysis of single lipid bodies from two different sets of breast tumor and normal adjacent tissues to elucidate the fatty acid composition of triglycerides using One-Cell analysis coupled to tandem mass spectrometry.



The metabolic syndrome: A high-risk state for cancer?

It is proposed that the metabolic syndrome be considered as a high-risk state for certain types of cancer and that this relationship should be systematically explored across cancer types.

Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project

The metabolic syndrome was associated with a decreased risk of incident breast cancer in women below age 50 with high body mass index, and with an increased risk of breast cancer mortality in women above 60.

Metabolic syndrome and endometrial carcinoma.

The association between the metabolic syndrome and endometrial carcinoma risk seems to go beyond the risk conferred by obesity alone, particularly in women with a high body mass index.

Serum lipid profile of breast cancer patients.

The association between dyslipidaemia, BMI and increased breast cancer risk is confirmed and the lipid profile generally increased with age in both subjects and controls with the subjects having a much higher value than the corresponding control.

Serum lipids and tissue DNA content in Egyptian female breast cancer patients.

An association between high levels of serum, total lipid and total cholesterol, and increased breast cancer risk in premenopausal women is suggested and also suggested for the high total serum lipid and triglyceride levels in post menopausal women.

Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women

No association between breast cancer risk and blood lipids was found in the total population, nor when the data were divided into those diagnosed before or after the age of 50 as a dividing line between pre- and postmenopausal diagnosis.

Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project

Peri/postmenopausal women had a significantly increased age‐adjusted relative risk of breast cancer associated with height, and the RR was increased over quartiles of cholesterol levels, and no other significant associations were found.

Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer

The alterations in lipid profile levels showed a significant correlation with breast cancer risk, disease status, and treatment outcome.

Obesity, metabolic syndrome, and prostate cancer.

Whether obesity and metabolic syndrome modulate the risk of prostate cancer through chronic inflammation needs to be investigated further.

Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) project. Cancer Epidemiology, Biomarkers

  • Prevention
  • 2010